Liothyronine Sodium 00093-2179-01

Package NDC

00093-2179-01

Manufacturer: Teva Pharmaceuticals Usa, Inc.
Dosage Form: Tablet
Route: Oral
Product Type: Human Prescription Drug
Marketing Start: February 26, 2021
Listing Expires: December 31, 2026
Application: ANDA211510

Need to source Liothyronine Sodium? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Liothyronine Sodium	5 ug/1

Drug Class

Triiodothyronine [CS]l-Triiodothyronine [EPC]

Selected Package

00093-2179-01Selected

100 TABLET in 1 BOTTLE (0093-2179-01)